AUDIOEYE INC (AEYE) Stock Fundamental Analysis
NASDAQ:AEYE - Nasdaq - US0507342014 - Common Stock - Currency: USD
Taking everything into account, AEYE scores 3 out of 10 in our fundamental rating. AEYE was compared to 281 industry peers in the Software industry. AEYE has a bad profitability rating. Also its financial health evaluation is rather negative. AEYE is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
AEYE had negative earnings in the past year.
AEYE had a positive operating cash flow in the past year.
In the past 5 years AEYE always reported negative net income.
In multiple years AEYE reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -14.29%, AEYE is doing worse than 64.06% of the companies in the same industry.
Looking at the Return On Equity, with a value of -45.08%, AEYE is doing worse than 67.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.29% | ||
| ROE | -45.08% | ||
| ROIC | N/A |
ROA(3y)-26.67%
ROA(5y)-33.65%
ROE(3y)-77.04%
ROE(5y)-81.35%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 79.37%, AEYE belongs to the best of the industry, outperforming 80.07% of the companies in the same industry.
AEYE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for AEYE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 79.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.9%
GM growth 5Y6.09%
2. Health
2.1 Basic Checks
AEYE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AEYE has been increased compared to 1 year ago.
The number of shares outstanding for AEYE has been increased compared to 5 years ago.
AEYE has a better debt/assets ratio than last year.
2.2 Solvency
AEYE has an Altman-Z score of 0.45. This is a bad value and indicates that AEYE is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.45, AEYE is not doing good in the industry: 66.55% of the companies in the same industry are doing better.
AEYE has a debt to FCF ratio of 8.63. This is a slightly negative value and a sign of low solvency as AEYE would need 8.63 years to pay back of all of its debts.
AEYE's Debt to FCF ratio of 8.63 is in line compared to the rest of the industry. AEYE outperforms 52.31% of its industry peers.
AEYE has a Debt/Equity ratio of 0.72. This is a neutral value indicating AEYE is somewhat dependend on debt financing.
The Debt to Equity ratio of AEYE (0.72) is worse than 70.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | 8.63 | ||
| Altman-Z | 0.45 |
ROIC/WACCN/A
WACC10.88%
2.3 Liquidity
AEYE has a Current Ratio of 1.05. This is a normal value and indicates that AEYE is financially healthy and should not expect problems in meeting its short term obligations.
AEYE has a Current ratio of 1.05. This is in the lower half of the industry: AEYE underperforms 74.38% of its industry peers.
A Quick Ratio of 1.05 indicates that AEYE should not have too much problems paying its short term obligations.
AEYE has a worse Quick ratio (1.05) than 73.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 66.67% over the past year.
AEYE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.41%.
AEYE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.73% yearly.
EPS 1Y (TTM)66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%314.29%
Revenue 1Y (TTM)12.41%
Revenue growth 3Y12.84%
Revenue growth 5Y26.73%
Sales Q2Q%20.38%
3.2 Future
Based on estimates for the next years, AEYE will show a very strong growth in Earnings Per Share. The EPS will grow by 72.10% on average per year.
Based on estimates for the next years, AEYE will show a quite strong growth in Revenue. The Revenue will grow by 18.29% on average per year.
EPS Next Y144.3%
EPS Next 2Y72.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.92%
Revenue Next 2Y18.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AEYE. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 35.35 indicates a quite expensive valuation of AEYE.
AEYE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AEYE is cheaper than 63.35% of the companies in the same industry.
AEYE's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 35.35 |
4.2 Price Multiples
AEYE's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 187.54 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AEYE's earnings are expected to grow with 72.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.1%
EPS Next 3YN/A
5. Dividend
5.1 Amount
AEYE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
11.9
+0.82 (+7.4%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners39.55%
Inst Owner Change1.64%
Ins Owners32.45%
Ins Owner Change7.94%
Market Cap148.16M
Analysts81.82
Price Target24.89 (109.16%)
Short Float %7.49%
Short Ratio3.67
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-1.99%
Max Revenue beat(2)-1.75%
Revenue beat(4)0
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-1.99%
Max Revenue beat(4)-1.38%
Revenue beat(8)0
Avg Revenue beat(8)-1.89%
Revenue beat(12)0
Avg Revenue beat(12)-1.76%
Revenue beat(16)0
Avg Revenue beat(16)-1.8%
PT rev (1m)-14.08%
PT rev (3m)-29.53%
EPS NQ rev (1m)112.5%
EPS NQ rev (3m)120%
EPS NY rev (1m)533.33%
EPS NY rev (3m)41.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.5%
Revenue NY rev (1m)-2.56%
Revenue NY rev (3m)-2.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 35.35 | ||
| P/S | 4.21 | ||
| P/FCF | 187.54 | ||
| P/OCF | 54.25 | ||
| P/B | 15.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.13
EYN/A
EPS(NY)0.34
Fwd EY2.83%
FCF(TTM)0.06
FCFY0.53%
OCF(TTM)0.22
OCFY1.84%
SpS2.83
BVpS0.76
TBVpS-0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.29% | ||
| ROE | -45.08% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 79.37% | ||
| FCFM | 2.24% |
ROA(3y)-26.67%
ROA(5y)-33.65%
ROE(3y)-77.04%
ROE(5y)-81.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.9%
GM growth 5Y6.09%
F-Score5
Asset Turnover1.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | 8.63 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 76.75% | ||
| Cap/Sales | 5.51% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 0.45 |
F-Score5
WACC10.88%
ROIC/WACCN/A
Cap/Depr(3y)77.02%
Cap/Depr(5y)97.08%
Cap/Sales(3y)5.53%
Cap/Sales(5y)5.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%314.29%
EPS Next Y144.3%
EPS Next 2Y72.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.41%
Revenue growth 3Y12.84%
Revenue growth 5Y26.73%
Sales Q2Q%20.38%
Revenue Next Year17.92%
Revenue Next 2Y18.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year645.21%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y142.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y758.81%
OCF growth 3YN/A
OCF growth 5YN/A